| pubmed-article:58926 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:58926 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:58926 | lifeskim:mentions | umls-concept:C0007452 | lld:lifeskim |
| pubmed-article:58926 | lifeskim:mentions | umls-concept:C0026969 | lld:lifeskim |
| pubmed-article:58926 | lifeskim:mentions | umls-concept:C0033684 | lld:lifeskim |
| pubmed-article:58926 | lifeskim:mentions | umls-concept:C0017814 | lld:lifeskim |
| pubmed-article:58926 | lifeskim:mentions | umls-concept:C0027021 | lld:lifeskim |
| pubmed-article:58926 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:58926 | lifeskim:mentions | umls-concept:C1160466 | lld:lifeskim |
| pubmed-article:58926 | lifeskim:mentions | umls-concept:C0597879 | lld:lifeskim |
| pubmed-article:58926 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:58926 | pubmed:dateCreated | 1976-8-23 | lld:pubmed |
| pubmed-article:58926 | pubmed:abstractText | The effects of the immunoreactivity of bovine myelin encephalitogenic protein (EP) of treatment with glutaraldehyde and conjugation with horeradish peroxidase (HRP) were investigated by complement fixation and immunohistochemistry. Both glutaraldehyde treatment and HRP conjugation of EP decreased but did not abolish the reactivity of EP with rabbit anti-EP. Conjugation of EP to HRP by the two-step method of Avrameas had less detrimental effects on the immunochemical reactivity of EP than did the one-step procecure. The use of EP-HRP conjugates to probe for antibodies to EP is an immunochemically sound system with the major limitation that the number of antibody-producing cells is likely to be underestimated due to the failure to detect cells producing low levels of antibody or antibodies directed toward determinants altered by the modification procedures. | lld:pubmed |
| pubmed-article:58926 | pubmed:language | eng | lld:pubmed |
| pubmed-article:58926 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:58926 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:58926 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:58926 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:58926 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:58926 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:58926 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:58926 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:58926 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:58926 | pubmed:month | May | lld:pubmed |
| pubmed-article:58926 | pubmed:issn | 0022-1554 | lld:pubmed |
| pubmed-article:58926 | pubmed:author | pubmed-author:WhitakerJ NJN | lld:pubmed |
| pubmed-article:58926 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:58926 | pubmed:volume | 24 | lld:pubmed |
| pubmed-article:58926 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:58926 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:58926 | pubmed:pagination | 652-8 | lld:pubmed |
| pubmed-article:58926 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:58926 | pubmed:meshHeading | pubmed-meshheading:58926-An... | lld:pubmed |
| pubmed-article:58926 | pubmed:meshHeading | pubmed-meshheading:58926-An... | lld:pubmed |
| pubmed-article:58926 | pubmed:meshHeading | pubmed-meshheading:58926-Ly... | lld:pubmed |
| pubmed-article:58926 | pubmed:meshHeading | pubmed-meshheading:58926-Gu... | lld:pubmed |
| pubmed-article:58926 | pubmed:meshHeading | pubmed-meshheading:58926-Ca... | lld:pubmed |
| pubmed-article:58926 | pubmed:meshHeading | pubmed-meshheading:58926-Al... | lld:pubmed |
| pubmed-article:58926 | pubmed:meshHeading | pubmed-meshheading:58926-Ra... | lld:pubmed |
| pubmed-article:58926 | pubmed:meshHeading | pubmed-meshheading:58926-Me... | lld:pubmed |
| pubmed-article:58926 | pubmed:meshHeading | pubmed-meshheading:58926-Pe... | lld:pubmed |
| pubmed-article:58926 | pubmed:meshHeading | pubmed-meshheading:58926-Co... | lld:pubmed |
| pubmed-article:58926 | pubmed:meshHeading | pubmed-meshheading:58926-Fl... | lld:pubmed |
| pubmed-article:58926 | pubmed:meshHeading | pubmed-meshheading:58926-El... | lld:pubmed |
| pubmed-article:58926 | pubmed:meshHeading | pubmed-meshheading:58926-Gl... | lld:pubmed |
| pubmed-article:58926 | pubmed:meshHeading | pubmed-meshheading:58926-Ho... | lld:pubmed |
| pubmed-article:58926 | pubmed:meshHeading | pubmed-meshheading:58926-My... | lld:pubmed |
| pubmed-article:58926 | pubmed:year | 1976 | lld:pubmed |
| pubmed-article:58926 | pubmed:articleTitle | The effects of glutaraldehyde treatment and horesradish peroxidase conjugation on the immunoreactivity of bovine myelin encephalitogenic protein. | lld:pubmed |
| pubmed-article:58926 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:58926 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:58926 | lld:pubmed |
